Penumbra, Inc has announced it has secured CE Mark in Europe for its latest computer assisted vacuum thrombectomy (CAVT) technologies, Lightning Flash 2.0 and Lightning Bolt 7. Penumbra says its Lightning products will be the only CAVT systems available in Europe and each are designed to help physicians optimise patient care.

James F. Benenati, M.D., FSIR, Chief Medical Officer at Penumbra said: “Based on outcomes from our clinical trials and from physicians using our devices globally, our CAVT technologies have greatly improved our ability to rapidly and safely remove clot in the vascular system. With quicker procedures and more efficient clot removal, we have improved outcomes while demonstrating a high level of safety. As adoption of thrombectomy becomes more widespread, Lightning Flash 2.0 and Lightning Bolt 7 will provide physicians in Europe with the confidence that CAVT is a valuable first line option to manage conditions such as PE, venous thrombosis, and acute limb ischemia.”   

Penumbra says that Lightning Flash 2.0 is the ‘most advanced’ mechanical thrombectomy system on the market to address venous and pulmonary thrombus. It features Penumbra’s Lightning Intelligent Aspiration technology with the latest dual clot detection algorithms, using both pressure and flow-based processes to detect blood clot and blood flow.